Summary
STSS Chart
Aegis Capital Corp. Acted as Exclusive Placement Agent on a $3.5 Million Bridge Financing for Sharps Technology, Inc. (NASDAQ:STSS)
NEW YORK, NY / ACCESSWIRE / September 27, 2024 / Aegis Capital Corp. acted as Exclusive Placement Agent on a $3.5 Million Bridge Financing for Sharps Technology, Inc. (NASDAQ:STSS). About Sharps Technology, Inc. Sharps Technology, Inc., a medical device company, engages in the design, research and development, manufacturing, and commercialization of safety syringe products in the United States.
What's Going On With Nano-Cap Medical Device-Focused Sharps Technology On Friday?
Shares of Sharps Technology Inc STSS are trading higher on Friday, with a heavy session volume of 15.17 million.
Why Is Sharps Technology (STSS) Stock Up 21% Today?
Sharps Technology (NASDAQ: STSS ) stock is up on Thursday after the medical device company announced a $30 million purchase order for its specialty copolymer prefillable syringes. Sharps Technology says this purchase order comes from Nephron Pharmaceuticals.
Sharps Technology Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Matthew Friedwald ParaFi Capita LLP | 2.15M | $3.04M | $2.73M | -$311,469.4 | -10.24% |
 Hui Fai Tam Caitong International Asset Management Co. Ltd. | 1 | $1.6 | $1.31 | -$0.29 | -18.12% |
 Matthew Gorham Pantera Capital Partners LP | 1.15M | $7.5M | $1.46M | -$6.04M | -80.52% |
Sharps Technology Inc. (STSS) FAQ
What does "Delisted" mean?
What was the last recorded dividend?
How long did the company pay dividends?
Were there any stock splits?
What was the last known trading price?
Sharps Technology Inc. Profile
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Paul K. Danner CEO | NASDAQ (CM) Exchange | 82003F309 CUSIP |
| US Country | 55 Employees | - Last Dividend | 28 Apr 2025 Last Split | 14 Apr 2022 IPO Date |
Overview
Sharps Technology, Inc. is a cutting-edge medical device company specialized in the research, design, development, manufacturing, distribution, and sale of safety syringe products. Established in 2017 and headquartered in Melville, New York, the company focuses on providing innovative solutions to increase the safety and efficacy of vaccine and medication administration. Sharps Technology, Inc.'s mission is to address the critical need for safer medical syringes in the healthcare sector, aiming to minimize needle-related injuries and infections, thereby safeguarding healthcare professionals and patients alike.
Products and Services
- Sharps Provensa:
This flagship product of Sharps Technology, Inc., is an ultra-low waste space syringe designed for the precise administration of vaccines and injectable medications. The Sharps Provensa syringe is distinguished by its innovative design that minimizes waste, ensuring maximum dosage efficiency and reducing environmental impact. Aimed at healthcare facilities and professionals, this product encapsulates the company's dedication to improving medical practices and patient care through advanced technology.
